122 related articles for article (PubMed ID: 16005948)
1. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose.
Carrera MR; Trigo JM; Wirsching P; Roberts AJ; Janda KD
Pharmacol Biochem Behav; 2005 Aug; 81(4):709-14. PubMed ID: 16005948
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a cocaine-binding antibody.
Larsen NA; Zhou B; Heine A; Wirsching P; Janda KD; Wilson IA
J Mol Biol; 2001 Aug; 311(1):9-15. PubMed ID: 11469854
[TBL] [Abstract][Full Text] [Related]
3. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality.
Macêdo DS; Santos RS; Belchior LD; Neto MA; Vasconcelos SM; Lima VT; Fonteles MM; Viana GS; de Sousa FC
Epilepsy Behav; 2004 Dec; 5(6):852-6. PubMed ID: 15582832
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.
Byrnes-Blake KA; Laurenzana EM; Landes RD; Gentry WB; Owens SM
Eur J Pharmacol; 2005 Oct; 521(1-3):86-94. PubMed ID: 16182279
[TBL] [Abstract][Full Text] [Related]
5. Development of monoclonal antibodies directed against cocaine and cocaethylene: potential new tools for immunotherapy.
Danger Y; Devys A; Gadjou C; Galons H; Blanchard D; Folléa G
Hybrid Hybridomics; 2004 Aug; 23(4):212-8. PubMed ID: 15319068
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
Hoffman RS; Henry GC; Wax PM; Weisman RS; Howland MA; Goldfrank LR
J Pharmacol Exp Ther; 1992 Nov; 263(2):698-702. PubMed ID: 1432697
[TBL] [Abstract][Full Text] [Related]
7. Extremely low frequency magnetic field effects on premorbid behaviors produced by cocaine in the mouse.
Kim J; Baik KY; Lee BC; Kang SY; Shin SH; Soh KS
Bioelectromagnetics; 2004 May; 25(4):245-50. PubMed ID: 15114633
[TBL] [Abstract][Full Text] [Related]
8. Cocaine alters catalase activity in prefrontal cortex and striatum of mice.
Macêdo DS; de Vasconcelos SM; dos Santos RS; Aguiar LM; Lima VT; Viana GS; de Sousa FC
Neurosci Lett; 2005 Oct; 387(1):53-6. PubMed ID: 16085363
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.
Treweek JB; Roberts AJ; Janda KD
Pharmacol Biochem Behav; 2011 May; 98(3):474-84. PubMed ID: 21356233
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for the treatment of drug abuse.
Kosten T; Owens SM
Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218
[TBL] [Abstract][Full Text] [Related]
11. An antidote for acute cocaine toxicity.
Treweek JB; Janda KD
Mol Pharm; 2012 Apr; 9(4):969-78. PubMed ID: 22380623
[TBL] [Abstract][Full Text] [Related]
12. Anticocaine catalytic antibodies.
Deng SX; de Prada P; Landry DW
J Immunol Methods; 2002 Nov; 269(1-2):299-310. PubMed ID: 12379369
[TBL] [Abstract][Full Text] [Related]
13. Inhalational model of cocaine exposure in mice: neuroteratological effects.
He F; Lidow IA; Lidow MS
Neurotoxicol Teratol; 2006; 28(2):181-97. PubMed ID: 16414242
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies.
Meijler MM; Kaufmann GF; Qi L; Mee JM; Coyle AR; Moss JA; Wirsching P; Matsushita M; Janda KD
J Am Chem Soc; 2005 Mar; 127(8):2477-84. PubMed ID: 15725002
[TBL] [Abstract][Full Text] [Related]
15. A second-generation vaccine protects against the psychoactive effects of cocaine.
Carrera MR; Ashley JA; Wirsching P; Koob GF; Janda KD
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1988-92. PubMed ID: 11172063
[TBL] [Abstract][Full Text] [Related]
16. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.
Witkin JM; Levant B; Zapata A; Kaminski R; Gasior M
J Pharmacol Exp Ther; 2008 Sep; 326(3):930-8. PubMed ID: 18566292
[TBL] [Abstract][Full Text] [Related]
17. Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol.
Shah NG; Lathrop SL; Reichard RR; Landen MG
Addiction; 2008 Jan; 103(1):126-36. PubMed ID: 18028518
[TBL] [Abstract][Full Text] [Related]
18. Is immunotherapy an opportunity for effective treatment of drug addiction?
Zalewska-Kaszubska J
Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911
[TBL] [Abstract][Full Text] [Related]
19. A human recombinant monoclonal antibody to cocaine: Preparation, characterization and behavioral studies.
Eubanks LM; Ellis BA; Cai X; Schlosburg JE; Janda KD
Bioorg Med Chem Lett; 2014 Oct; 24(19):4664-4666. PubMed ID: 25205191
[TBL] [Abstract][Full Text] [Related]
20. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
Kuhar MJ; Carroll FI; Bharat N; Landry DW
Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
